Small-Cap Firms Dominate Thursday’s Gains. In this article, we are going to take a look at where Plus Therapeutics Inc.

Nanobiotix S.A. Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose ...

Plus Therapeutics shares are trading higher by 183% during Thursday's session. The company announced that the FDA accepted ...

The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.

Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a ...

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of re-irradiation with JNJ-1900 (NBTXR3) for patients ...

Plus Therapeutics, Inc. (NASDAQ:PSTV) saw a 177.57% increase in stock price, likely due to FDA’s conditional acceptance of REYOBIQ™. Impact BioMedical Inc. (NYSE American:IBO) experienced a 170.06% ...

In the upcoming installments, we will explore the impact of Western sanctions, the consequences of Ukrainian drone strikes on ...

The Fellows of the AACR Academy have elected Elaine V. Fuchs, PhD, FAACR, as their next President. She will assume the ...